In a study of 5,700 patients hospitalized with COVID-19 in the New York City area, the mortality rates for patients with hypertension not taking an ACE inhibitors or ARBs at admission, taking an ACE inhibitor, or taking an ARB were comparable (8). Here, ACE is linked to Hypertension.